A carregar...
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
Tedizolid phosphate is the first once-daily oxazolidinone approved by the United States Food and Drug Administration for the treatment of acute bacterial skin and skin structure infections (ABSSSI). It is more potent in vitro than linezolid against methicillin-resistant Staphylococcus aureus (MRSA)...
Na minha lista:
| Publicado no: | Infect Drug Resist |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411017/ https://ncbi.nlm.nih.gov/pubmed/25960671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S56691 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|